Journals / Retina-Vitreus / 2013 / Cilt: 21 - Sayı: 4

Non-arteritik iskemik optik nöropatide intravitreal bevasizumab tedavisi

Intravitreal bevacizumab therapy in non-arteritic anterior ıschemic optic neuropathy

Pages
295–298
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Bevacizumab did not seem to improve visual outcome in non-arteritic ischemic optic neuropathy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Up to date there is no golden standard for the treatment of non-arteritic ischemic optic neuropathy.
📊
Key Findings & Data:In the first case, visual acuity changed from 2/200 to 20/400 at 2 week and 4/200 at one year.
💡
Conclusion & Impact:Bevacizumab did not seem to improve visual outcome in non-arteritic ischemic optic neuropathy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Up to date there is no golden standard for the treatment of non-arteritic ischemic optic neuropathy. Here we report two cases which underwent intravitreal bevacizumab injection for non-arteritic ischemic optic neuropathy. In the first case, visual acuity changed from 2/200 to 20/400 at 2 week and 4/200 at one year. In the second case, visual acuity decreased from 20/30 to 20/400 with a worsened visual field defect at 6 week and to 20/200 at 5.5 month. Bevacizumab did not seem to improve visual outcome in non-arteritic ischemic optic neuropathy.

Özet

Günümüzde non-arteritik iskemik optik nöropati tedavisinde altın standart bulunmamaktadır. Bu yazıda non-arteritik iskemik optik nöropati nedeniyle intravitreal bevasizumab enjeksiyonu yapılan iki olgu bildirilmektedir. İlk olguda 0.01 olan görme keskinliği tedaviden sonraki ikinci haftada 0.05, 1. yılda ise 0.01 saptanmıştır. İkinci olguda ise 0.7 olan görme keskinliği tedaviden sonraki 6. haftada 0.05 e düşmüş ve görme alanı defekti artmış, 5.5 ayda ise 0.1 olarak izlenmiştir. Non-arteritik iskemik optik nöropatide bevasizumabın görsel sonuçlara olumlu bir etkisi saptanmamıştır.

🔖

Cite This Article

ÇETİN, E. N., AKDUMAN, L. (2013). Non-arteritik iskemik optik nöropatide intravitreal bevasizumab tedavisi. Retina-Vitreus, Cilt: 21 - Sayı: 4, 295–298. https://ajindex.com/articles/305072

References (1)

  1. Hayreh SS, Zimmerman MB. Non-arteritic anterior ischemic optic neuropathy:Role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol 2008;246:1029-46. 2.Kaderli B, Avci R, Yucel A, et al. Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 2007;27:164-8. 3.Yaman A, Selver OB, Saatci AO, et al. Intravitreal triamcino-lone acetonide injection for acute non-arteritic anterior ischaemic optic neuropathy. Clin Exp Optom 2008;91:561-4. 4.Bennett JL, Thomas S, Olson JL, et al. Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab. J Neuroophthalmol 2007;27:238-40. 5.Bajin MS, Selver OB, Taskin O, et al. Single intravitreal ranibizumab injection in eyes with acute non-arteritic anterior ischaemic optic neuropathy. Clin Exp Optom 2011;94:367-70. 6.Prescott CR, Sklar CA, Lesser RL, et al. Is intravitreal bevaci-zumab an effective treatment option for nonarteritic anterior ischemic optic neuropathy? J Neuroophthalmol 2012;32;51-3. 7.Huang JY, Ozaki H, Hayashi H, et al. Anterior ischemic optic neuropathy following intravitreal bevacizumab. Jpn J Ophthalmol 2010;54:252-4. 8.Hosseini H, Razeghinejad MR. Anterior ischemic optic neuropathy after intravitreal injection of bevacizumab. J Neuroophthalmol 2009;29:160-1. 9.Bodla AA, Rao P. Non-arteritic ischemic optic neuropathy followed by intravitreal bevacizumab injection: is there an association? Indian J Ophthalmol 2010;58:349-50. 10.Ganssauge M, Wilhelm H, Bartz-Schmidt KU, et al. Nonarteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angoid streaks in pseudoxanthoma elasticum. Graefes Arch Clin Exp Ophthalmol 2009;247:1707-10.